Results 11 to 20 of about 304,742 (351)

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma [PDF]

open access: yesHistopathology, 2007
Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopathological parameters, coexpression of other biological markers and prognosis.
Arnerlov C   +10 more
core   +3 more sources

Ductal Carcinoma In Situ of the Breast [PDF]

open access: yesArchives of Surgery, 1998
Ductal carcinoma in situ (DCIS) of the breast is an expansion of the terminal duct lobular units and draining ducts by cytologically malignant cells confined within the basement membrane of the breast tree. Often considered as a single entity, it is a heterogeneous group of lesions which differ in their growth pattern, cytological features and ...
David L. Page, J.M. Dixon
  +10 more sources

Ductal carcinoma in situ of the breast [PDF]

open access: yesOncology Reviews, 2009
Ductal carcinoma in situ (DCIS) of the breast is a noninvasive form of breast cancer that has increased in incidence over the past several decades secondary to screening mammography. DCIS now represents 20–30% of all newly diagnosed cases of breast cancer.
Steven J. Buskirk   +3 more
openaire   +2 more sources

The application of multiple metrics in deformable image registration for target volume delineation of breast tumor bed

open access: yesJournal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Background and purpose For postoperative breast cancer patients, deformable image registration (DIR) is challenged due to the large deformations and non‐correspondence caused by tumor resection and clip insertion. To deal with it, three metrics (fiducial‐, region‐, and intensity‐based) were jointly used in DIR algorithm for improved accuracy ...
Xin Xie   +6 more
wiley   +1 more source

Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients

open access: yesWomen's Health, 2020
Objective: Population-wide mammographic screening programs aim to reduce breast cancer mortality. However, a broad view of the harms and benefits of these programs is necessary to favor informed decisions, especially in the earliest stages of the disease.
Julieta Politi   +6 more
doaj   +1 more source

Invasive Lobular Carcinoma of Breast with Extracellular Mucin: A Novel Entity

open access: yesJournal of Medical Sciences and Health, 2023
Invasive carcinoma of no special type (NST) or ductal carcinoma is the most common type of invasive breast cancers. Invasive lobular carcinoma (ILC) is the most common special variant amongst breast cancers that lacks some of the common features
Md. Samim Iqbal   +5 more
doaj   +1 more source

Contralateral prophylactic mastectomies. Correlations between primary tumor and histological findings of controlateral breast [PDF]

open access: yes, 2016
Backgound: In Italy in 2015 48,000 new cases of breast carcinomas were diagnosed. Women who are diagnosed with breast cancer have a significant risk of developing contralateral breast cancer during the rest of their lives and this risk is closely ...
Amanti, Claudio   +10 more
core   +1 more source

The shifting nature of women’s experiences and perceptions of ductal carcinoma in situ [PDF]

open access: yes, 2011
Aim: This paper is a report of a descriptive qualitative study of the evolution of women’s perceptions and experiences of ductal carcinoma in situ from the period near to diagnosis to one year later.
Baum   +51 more
core   +1 more source

Ductal Carcinoma in Situ of the Breast

open access: yesNew England Journal of Medicine, 2004
Ductal carcinoma in situ of the breast (also called intraductal carcinoma), a clonal proliferation of malignant-appearing cells within the mammary duct lumens without evidence of invasion beyond the epithelial basement membrane, is the precursor lesion of invasive breast cancer.
Carolyn M. Kaelin   +4 more
  +8 more sources

Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells.

open access: yesPLoS ONE, 2017
BackgroundResistance to human epidermal growth factor receptor-2 (HER2)-targeted therapies is common, and results in treatment failure and new tumor progression.
Wen Che, Yun Bao, Feng Tang
doaj   +1 more source

Home - About - Disclaimer - Privacy